Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MAZE

Maze Therapeutics, Inc.

CIK 0001842295 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$29.43
↑ 0.50 (1.73%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.63B
P/E Ratio
-12.24
EPS
-3.05
Dividend Yield
Not covered
52W Position
41%
Beta
1.03

Valuation multiples

Fwd P/E
8.53
PEG
Not covered
P/B
3.61
P/S
Not covered
EV/Revenue
Not covered
ROE
-29.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 41%
$12.91$53.65

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$131.12M
Total Assets
$397.13M
Free Cash Flow
-$112.73M

Recent news